Insider Transactions in Q2 2025 at Rhythm Pharmaceuticals, Inc. (RYTM)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2025
|
Christopher Paul German Corporate Controller & CAO |
SELL
Open market or private sale
|
Direct |
2,069
-52.27%
|
$138,623
$67.19 P/Share
|
|
Jun 10
2025
|
Christopher Paul German Corporate Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,069
+21.27%
|
$18,173
$17.97 P/Share
|
|
Jun 06
2025
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
7,031
-26.8%
|
$478,108
$68.05 P/Share
|
|
Jun 06
2025
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,031
+21.13%
|
$42,186
$6.8 P/Share
|
|
Jun 03
2025
|
David P Meeker President and CEO |
SELL
Open market or private sale
|
Direct |
43,620
-8.9%
|
$2,835,300
$65.32 P/Share
|
|
Jun 03
2025
|
David P Meeker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
43,620
+15.09%
|
$174,480
$4.59 P/Share
|
|
Jun 03
2025
|
David W J Mcgirr Director |
SELL
Open market or private sale
|
Direct |
65,431
-78.94%
|
$4,253,015
$65.4 P/Share
|
|
Jun 03
2025
|
David W J Mcgirr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
65,431
+48.88%
|
$261,724
$4.59 P/Share
|
|
May 30
2025
|
Hunter C Smith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,400
-9.02%
|
$1,427,400
$61.23 P/Share
|
|
May 30
2025
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,400
+14.93%
|
$140,400
$6.88 P/Share
|
|
Apr 29
2025
|
Yann Mazabraud EVP, Head of International |
SELL
Open market or private sale
|
Direct |
6,745
-15.19%
|
$438,425
$65.08 P/Share
|
|
Apr 29
2025
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
7,031
-26.8%
|
$457,015
$65.09 P/Share
|
|
Apr 29
2025
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,031
+21.13%
|
$42,186
$6.8 P/Share
|
|
Apr 15
2025
|
Yann Mazabraud EVP, Head of International |
BUY
Exercise of conversion of derivative security
|
Direct |
11,405
+20.44%
|
-
|
|
Apr 14
2025
|
Yann Mazabraud EVP, Head of International |
BUY
Exercise of conversion of derivative security
|
Direct |
10,375
+23.92%
|
-
|
|
Apr 08
2025
|
Yann Mazabraud EVP, Head of International |
SELL
Open market or private sale
|
Direct |
17,750
-25.03%
|
$1,065,000
$60.96 P/Share
|
|
Apr 08
2025
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
20,760
-16.25%
|
$1,224,840
$59.84 P/Share
|
|
Apr 08
2025
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,760
+22.03%
|
$352,920
$17.08 P/Share
|